Results 1 to 10 of about 52,862 (295)

Fracture Risk Associated With Long‐Term Discontinuation of Postmenopausal Osteoporosis Treatment: A French Population‐Based Study Using National Claims Data (Système National des Données de Santé) [PDF]

ACR Open Rheumatology
Objective This retrospective cohort study evaluated the long‐term discontinuation (LTD) of osteoporosis treatments in postmenopausal women in France and associated fracture risk and economic burden.
Audrey Lajoinie, Meriem Benmerad, Magali Laborey, Pascale Samama, Gaëlle Désaméricq, Leila Chelbani, Karine Briot   +6 more
doaj   +2 more sources

Bisphosphonates [PDF]

Turkish Journal of Orthodontics, 2009
Bisphosphonates are used with the purpose of preventing bone resorption in some metabolic bone diseases. These drugs have been introduced into clinical use about 30 years ago and widely used in nowadays. As Orthodontic some different researches have been
Fırat Öztürk
doaj   +2 more sources

Hydroxy- and Amino-Phosphonates and -Bisphosphonates: Synthetic Methods and Their Biological Applications

Frontiers in Chemistry, 2022
Phosphonates and bisphosphonates are stable analogs of phosphates and pyrophosphates that are characterized by one and two carbon–phosphorus bonds, respectively.
Babak Kaboudin, Payam Daliri, Samaneh Faghih, Hesam Esfandiari   +3 more
doaj   +1 more source

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review

Journal of Orthopaedic Translation, 2020
Objective: The objective of this study was to assess the efficacy and safety of denosumab therapy in osteoporotic postmenopausal women who were previously treated with bisphosphonates. Methods: Meta-analyses of four available randomised controlled trials
Yilin Zhu, Zhonglian Huang, Yan Wang, Weicai Xu, Hongjiang Chen, Jiankun Xu, Shaowei Luo, Yuantao Zhang, Di Zhao, Jun Hu   +9 more
doaj   +1 more source

Efficacy and safety of bisphosphonates on childhood osteoporosis secondary to chronic illness or its treatment: a meta-analysis

Therapeutic Advances in Chronic Disease, 2022
Background: Bisphosphonates are a type of medication that prevents the loss of bone density. Secondary childhood osteoporosis reduces bone strength and results in an increased risk of fragility fracture.
Huawei Zhao, Yunfei Ding, Jufei Yang, Yijun Luo, Zhenghao Xu, Jing Miao   +5 more
doaj   +1 more source

Atypical femur fractures associated with chronic bisphosphonates use: A case series with 66 patients [PDF]

Revista Brasileira de Ortopedia, 2022
Objective The present study aims to describe outcomes from a series of surgically treated patients with atypical femoral fracture due to bisphosphonates use, in addition to correlate the time of previous medication use with fracture consolidation time ...
Guilherme Guadagnini Falotico, Jose Fernando Flores Cunza, Gabriel Ferraz Ferreira, Victor Otávio Oliveira, Daniel Oksman, Gustavo Gonçalves Arliani   +5 more
doaj   +1 more source

Assessment Results of Dental Students' Knowledge about Bisphosphonates and Bisphosphonate-Related Osteonecrosis of the Jaw

eJournal of Oral Maxillofacial Research, 2023
Objectives: The aim of this cross-sectional study is to evaluate Lithuanian fourth- and fifth-year dental students' knowledge about bisphosphonates and bisphosphonate-related osteonecrosis of the jaw. Material and Methods: The anonymous survey using a
Greta Sereikaite, Vesta Guzeviciene, Gabriele Peceliunaite, Povilas Daugela, Gintaras Juodzbalys   +4 more
doaj   +1 more source

Bisphosphonates Target B Cells to Enhance Humoral Immune Responses

Cell Reports, 2013
Bisphosphonates are a class of drugs that are widely used to inhibit loss of bone mass in patients. We show here that the administration of clinically relevant doses of bisphosphonates in mice increases antibody responses to live and inactive viruses ...
Elena Tonti, Nereida Jiménez de Oya, Gabriele Galliverti, E. Ashley Moseman, Pietro Di Lucia, Angelo Amabile, Stefano Sammicheli, Marco De Giovanni, Laura Sironi, Nicolas Chevrier, Giovanni Sitia, Luigi Gennari, Luca G. Guidotti, Ulrich H. von Andrian, Matteo Iannacone   +14 more
doaj   +1 more source

Evaluation of trabecular bone changes according to the type of prosthesis in patients using bisphosphonates: a retrospective study [PDF]

Brazilian Oral Research, 2023
The objective of the study was to retrospectively compare the fractal size values calculated in the trabecular bone according to the type of complete removable denture, removable partial denture, and partial fixed prosthesis between patients using ...
Begüm Ünlü Kurşun, Ender Akan
doaj   +1 more source

Bisphosphonates and Atypical Hip Fractures: Current Status of Issue and Answers to Discussion Questions

Bolʹ, Sustavy, Pozvonočnik, 2012
The paper presents the recent data with the literature review on the controversial issue of the link between chronic administration of bisphosphonates, and atypical femoral shaft fractures.
I.Yu. Golovach
doaj   +1 more source